The largest database of trusted experimental protocols

8 protocols using pgk h2bmcherry

1

Plasmid Constructs for Cell Engineering

Check if the same lab product or an alternative is used in the 5 most similar protocols
pMXs-c-Myc was a gift from Shinya Yamanaka (Addgene plasmid #13375); pBABE-puro-RAS V12 was a gift from Bob Weinberg (Addgene plasmid #1768); MSCV-p53DD-iGFP was a gift from Wechsel-Reya lab; PGK-H2BmCherry was a gift from Mark Mercola (Addgene plasmid # 21217); PIK3CAH1047R was subcloned from pBabe-puro-HA-PIK3CAH1047R, a gift from Jean Zhao (Addgene plasmid # 12524), into PGK-H2BmCherry; 7xTcf-eGFP//SV40-PuroR (7TGP) was a gift from Roel Nusse (Addgene plasmid #24305); pTween-Luc-NOeGFP was a gift from Stassi lab. Inducible IPTG-driven shRNAs for Myc and constitutive shRNAs for Myz-1 were purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
2

Dual-Color Competition Assay for Gene Essentiality

Check if the same lab product or an alternative is used in the 5 most similar protocols
For validation of EPIKOL screen candidate hits, dual color competition assays were performed. Cas9-stable cells were transduced with either PGK-H2BmCherry (Addgene #21217) or PGK-H2BeGFP (Addgene #21210) viruses at high MOI ~5 to make sure every cell was fluorescently labeled. 50,000 cells were seeded in 12 well-plates, mCherry+ cells were transduced with LentiGuide-NT1 viruses, while eGFP+ cells were transduced with viruses carrying sgRNA-X for selected genes. For each gene, two different sgRNAs were used (Supplementary Table 2). After 16 h, viral media were changed with fresh media and next day puromycin selection was started. After 3 days of puromycin selection, mCherry+ and eGFP+ cells were mixed in a 1:1 ratio and re-seeded into 24-well plates in triplicates. One day after seeding, Day0 measurements were taken by acquiring 3 × 3 images with a 4× objective in Cytation5 (BioTek, USA). Cells were incubated for the subsequent 16 days, and images were taken at Day4, Day8, Day12, and Day16. Number of mCherry+ and eGFP+ cells were counted from images using Gen5 software (BioTek, USA) and each measurement was normalized to Day0 to determine the percentage of eGFP+ cells.
+ Open protocol
+ Expand
3

Live-cell Imaging of ZIKV-infected NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
NPC lines genetically modified for the expression of H2B-mcherry fusion protein were generated and used in the long-term live-cell imaging experiments. Lentiviral vectors were generated by transient transfection of HEK293FT cells with psPAX2, pMD2G, and PGK-H2BmCherry (Addgene plasmids: #12260, #21217, #12259)35 (link). NPCs were transduced with H2B-mCherry lentiviral vectors, expanded and imaged using the Operetta High Content Imaging System (PerkinElmer). The cells were mock- or ZIKV-infected and imaged from 24 to 72 h after infection. The cells were maintained in a chamber with controlled temperature (37 °C) and atmosphere (5% CO2). Images were captured at multiple points every 10 min. At least 500 mitoses were analyzed for each condition and were assessed for the presence of chromosome laggards, multipolarity and apoptosis induction during mitosis or interphase.
+ Open protocol
+ Expand
4

Plasmid Construction for Keratin Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro studies, plasmids pT7HMT-K14WT and pT7HMT-K5WT were created by subcloning the relevant cDNAs (1,419 bp for K14WT; 1,773 bp for K5WT) into a pT7HMT modified vector (which features a T7 promoter) using NcoI–BamHI and NdeI–BamHI restriction sites, respectively. For expression in mammalian cells, plasmids pBK-CMV His-GFP-K14WT and pBK-CMV His-GFP-K14C367A were generated by subcloning the cDNAs for K14WT and K14C367A fused to a His-GFP tag at the N terminus into a pBK-CMV vector backbone using SalI–NotI restriction sites (Lee et al., 2012 (link)). The cysteine-free variant of K14 (K14CF) was generated by replacing all five cysteines in K14WT with alanines using a QuikChange lightning multi site-directed mutagenesis kit (Agilent Technologies). Otherwise, cysteine point mutations were introduced into the K14WT cDNA via a QuikChange lightning site-directed mutagenesis kit (Agilent Technologies). For live cell imaging, plasmid pShuttle-CMV-H2B-mCherry was created by subcloning the H2B-mCherry cDNA (1,098 bp) from plasmid PGK-H2BmCherry (Addgene) into a pShuttle-CMV backbone (a gift from B. Vogelstein, Johns Hopkins University School of Medicine, Baltimore, MD) via KpnI–HindIII restriction sites.
+ Open protocol
+ Expand
5

Multifaceted Genome Editing Toolkit

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nek2A (clone ID: 38963) in pJP1563 and NuMA1 (clone ID: 871325) in pLenti6.3/V5-DEST were purchased from DNASU. LentiCRISPR-v2 (52961), pCW57-RFP-P2A-MCS (78933), pCW57-MCS1-P2A-MCS2 (80922), pCDH-EF1-FHC (64874), Flag-TurboID (124646), Tet-pLKO-neo (21916), pcDNA3-Plk4 (41165), pcDNA5-STIL (80266), PGK-H2B-mCherry (21217) and PGK-H2B-eGFP (21210) were purchased from Addgene.
Kinase-dead mutant (K37R) of Nek2A was derived from Nek2A in pJP1563 using Q5 Site-Directed Mutagenesis Kit (NEB) following the instructions of manufacturer. Oligos used for the SDM reaction are given in (Supplementary Table 2). Single guide RNA (sgRNA) oligos (Supplementary Table 3) for CRISPR/Cas9 knockout of Nek2A, C-Nap1 and Rootletin were cloned into LentiCRISPR-v2 as previously described [51 (link)]. Dox-inducible overexpressions of Nek2A and PLK4 were achieved by subcloning to pCW57-RFP-P2A-MCS and pCW57-MCS1-P2A-MCS2 respectively. Nek2A-WT and Nek2A-KD(K37R) cDNAs were subcloned to Flag-TurboID. To perform Co-IP using anti-FLAG antibody, Nek2A cDNA was subcloned into pCDH-EF1-FHC. Oligos for dox-inducible shRNA expression targeting KIF2C were cloned into Tet-pLKO-neo as previously described [52 (link)] and provided in (Supplementary Table 4).
+ Open protocol
+ Expand
6

CRISPR-Mediated LMNA Knockin Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in 6 well plates and transfected in triplicate with jetPRIME (Polyplus transfection) according to the manufacturer’s instructions. 1 μg of mCherry vector (PGK-H2BmCherry, Addgene #21217), 4 μg of CRISPR/cas9 vector (pX330-LMNA-gRNA1, Addgene #122507) and 1 μg of donor vector (pCR2.1 Clover-LMNA donor, Addgene #122508) were used. The percent of clover-positive cells among the transfected cells (inferred by mCherry staining) was analyzed by flow cytometry using a LSR-Fortessa FACS (BD Biosciences) and results were ploted using the FlowJo software. Statistical significance was determined using the Student’s t test.
+ Open protocol
+ Expand
7

Engineered Cardiac Transcription Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
All plasmids were constructed as previously described [5] (link) and can be found on Addgene using the following catalog numbers: Troponin T-GCaMP5-Zeo (46027), tetO-Hand2 (46028), tetO-NKX2.5 (46029), tetO-GATA4 (46030), tetO-MEF2C (46031), tetO-TBX5 (46032). Plasmids that were used from Addgene also include: FUdeltaGW-rtTA (19780), psPAX2 (12260), pMD2.G (12259), and PGK-H2B-mCherry (21217). All plasmids were amplified in STBL3 bacteria (Invitrogen) and prepared with Qiagen MidiPrep Kits.
+ Open protocol
+ Expand
8

Breast Cancer Cell Culture and Organotypic Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured at 5% CO2, humidified, and at 37°C. MCFDCIS cells (Asterand) were cultured in DME-F12, 5% horse serum, 20 ng/ml EGF, 0.5 μg/ml hydrocortisone, 100 ng/ml cholera toxin, 10 μg/ml insulin and 1X pen/strep. HCC1313 cells [81 (link)] were a gift from John Minna (UTSW). All cell lines were validated by Powerplex genotyping before use. HCC1313 cells were cultured in 5% FBS, RPMI. MCFDCIS cells stably expressing LifeAct-GFP (Addgene #46356, gift from Iain Cheeseman) and PGK-H2B:mCherry (Addgene #21217, gift of Mark Mercola; [82 (link)]) were generated as described [21 (link)]. Growth factor reduced Matrigel (BD Biosciences, 10-12 mg/ml stock concentration) and bovine dermal collagen I (BD Biosciences) were used for organotypic culture experiments. The antibodies used are listed in Supplementary Table S6.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!